Efficacy of prefrontal theta-burst stimulation in refractory depression: A randomized sham-controlled study

Brain

Volumn 137, Issue 7, 2014, Pages 2088-2098

  Li, Cheng Ta ^a,b   Chen, Mu Hong ^a   Juan, Chi Hung ^c   Huang, Hsiang Hsuan ^a   Chen, Li Fen ^a,b   Hsieh, Jen Chuen ^a,b   Tu, Pei Chi ^a,b   Bai, Ya Mei ^a,b   Tsai, Shin Jen ^a,b   Lee, Ying Chiao ^a,b   Su, Tung Ping ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

antidepressant efficacy; brain stimulation; sham response; theta burst stimulation; treatment refractory depression

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MIRTAZAPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTINUOUS THETA BURST TRANSCRANIAL MAGNETIC STIMULATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; INTERMITTENT THETA BURST TRANSCRANIAL MAGNETIC STIMULATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT SAFETY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THETA BURST TRANSCRANIAL MAGNETIC STIMULATION; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT RESPONSE; AGE; CLINICAL EFFECTIVENESS; INTERMITTENT CONTINUOUS THETA BURST TRANSCRANIAL MAGNETIC STIMULATION; MEDICAL DEVICE COMPLICATION; REVIEW; SEIZURE; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION;

ANTIDEPRESSANT EFFICACY; BRAIN STIMULATION; SHAM RESPONSE; THETA-BURST STIMULATION; TREATMENT-REFRACTORY DEPRESSION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903553668     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu109     Document Type: Article

References (43)

1. Aguirre I, Carretero B, Ibarra O, Kuhalainen J, Martínez J, Ferrer A, et al. Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression. J Affect Disord 2011; 130: 466-9.
2. Allen JJ, Urry HL, Hitt SK, Coan JA. The stability of resting frontal electroencephalographic asymmetry in depression. Psychophysiology 2004; 41: 269-80. (Pubitemid 38524099)
3. Baeken C, De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues Clin Neurosci 2011; 13: 139-45.
4. Berlim MT, Broadbent HJ, Van den Eynde F. Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol 2013a; 16: 1173-81.
5. Berlim MT, Van den Eynde F, Daskalakis ZJ. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression. Psychol Med 2013b; 43: 2245-54.
6. Berlim MT, Van den Eynde F, Daskalakis ZJ. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry 2013c; 74: e122-9.
7. Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a metaanalysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013d; 38: 543-51.
8. Berlim MT, Van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2013e; 1-15.
9. Brakemeier EL, Wilbertz G, Rodax S, Danker-Hopfe H, Zinka B, Zwanzger P, et al. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drugfree patients. J Affect Disord 2008; 108: 59-70. (Pubitemid 351418014)
10. Cardenas-Morales L, Gron G, Kammer T. Exploring the after-effects of theta burst magnetic stimulation on the human motor cortex: a functional imaging study. Hum Brain Mapp 2010; 2: 1948-60.
11. Cardenas-Morales L, Gron G, Kammer T. Exploring the after-effects of theta burst magnetic stimulation on the human motor cortex: a functional imaging study. Hum Brain Mapp 2011; 32: 1948-60.
12. Chistyakov AV, Rubicsek O, Kaplan B, Zaaroor M, Klein E. Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. Int J Neuropsychopharmacol 2010; 13: 387-93.
13. Ciobanu C, Girard M, Marin B, Labrunie A, Malauzat D. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age. J Affect Disord 2013; 150: 677-81.
14. Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry 2008; 53: 555-66.
15. Dumas R, Padovani R, Richieri R, Lançon C. Repetitive transcranial magnetic stimulation in major depression: response factor [in French]. Encephale 2012; 38: 360-8.
16. Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, et al. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry 2009a; 70: 177-84.
17. Fekadu A, Wooderson SC, Markopoulou K, Cleare AJ. The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry 2009b; 70: 952-7.
18. Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices 2011; 8: 85-95.
19. Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol 2006; 9: 641-54. (Pubitemid 46127397)
20. Gamboa OL, Antal A, Moliadze V, Paulus W. Simply longer is not better: reversal of theta burst after-effect with prolonged stimulation. Exp Brain Res 2010; 204: 181-7.
21. George MS, Taylor JJ, Short EB. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry 2013; 26: 13-8.
22. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003; 64: 1465-75. (Pubitemid 41270106)
23. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-96.
24. Herwig U, Fallgatter AJ, Höppner J, Eschweiler GW, Kron M, Hajak G, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry 2007; 191: 441-8. (Pubitemid 350069586)
25. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron 2005; 45: 201-6. (Pubitemid 40128115)
26. Huang YZ, Rothwell JC, Chen RS, Lu CS, Chuang WL. The theoretical model of theta burst form of repetitive transcranial magnetic stimulation. Clin Neurophysiol 2011; 122: 1011-8.
27. Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002; 51: 237-52. (Pubitemid 34142636)
28. Kozel FA, Nahas Z, deBrux C, Molloy M, Lorberbaum JP, Bohning D, et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci 2000; 12: 376-84. (Pubitemid 30663737)
29. Lemogne C, Mayberg H, Bergouignan L, Volle E, Delaveau P, Lehé ricy S, et al. Self-referential processing and the prefrontal cortex over the course of depression: a pilot study. J Affect Disord 2010; 124: 196-201.
30. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 2010; 67: 458-64.
31. Li CT, Bai YM, Tu PC, Lee YC, Huang YL, Chen TJ, et al. Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study. PLoS One 2012; 7: e46818.
32. Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL, et al. Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 2010a; 50: 347-56.
33. Li CT, Tu PC, Wang SJ, Chen MH, Su TP, Hsieh JC. Impaired prefrontothalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study. PLoS One 2013; 8: e70089.
34. Li CT, Wang SJ, Hirvonen J, Hsieh JC, Bai YM, Hong CJ, et al. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord 2010b; 127: 219-29.
35. Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34: 522-34.
36. O'Reardon JB, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-16. (Pubitemid 350060890)
37. Plewnia C, Pasqualetti P, Große S, Schlipf S, Wasserka B, Zwissler B, et al. Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial. J Affect Disord 2014; 156: 219-23.
38. Ruchsow M, Groen G, Kiefer M, Beschoner P, Hermle L, Ebert D, et al. Electrophysiological evidence for reduced inhibitory control in depressed patients in partial remission: a Go/Nogo study. Int J Psychophysiol 2008; 68: 209-18.
39. Ruhe HG, Rooijen RG, Spijker J, Peeters FP, Schene AH. Staging methods for treatment resistant depression. A systematic review. J Affect Disord 2012; 137: 35-45.
40. Rush AJ. Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry 2007; 68 Suppl 10: 8-10. (Pubitemid 47507831)
41. Samson AC, Meisenzahl C, Scheuerecker J, Rosea E, Schoepf V, Wiesmannd M, et al. Brain activation predicts treatment improvement in patients with major depressive disorder. J Psychiatr Res 2011; 45: 1214-22.
42. Sibille E, Morris H, Rama S. Kota R, David A, Lewis D. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol 2011; 14: 721-34.
43. Spronk D, Arns M, Bootsma A, van Ruth R, Fitzgerald PB. Long-term effects of left frontal rTMS on EEG and ERPs in patients with depression. Clin EEG Neurosci 2008; 39: 118-24.